BCG Vaccine
Showing 26 - 50 of 8,526
Tuberculosis Infection Trial in United States (BCG (Tokyo 172) vaccine, Placebo)
Recruiting
- Tuberculosis Infection
- BCG (Tokyo 172) vaccine
- Placebo
-
Birmingham, Alabama
- +5 more
Dec 16, 2021
Multiple Sclerosis Trial in Rome (Bacille Calmette-Guerin vaccine, Placebo)
Recruiting
- Multiple Sclerosis
- Bacille Calmette-Guerin vaccine
- Placebo
-
Rome, ItalyCenter for Experimental Neurological Therapies (CENTERS), S. And
Jun 4, 2021
Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))
Active, not recruiting
- Newborn Vaccine Immunogenicity
- Hepatitis B vaccine (HBV)
- Bacillus Calmette-Guérin (BCG)
-
Fajara, Gambia
- +1 more
Jan 12, 2023
Vaccine Preventable Disease, Measles, Mother-Infant Interaction Trial in Bissau (BCG vaccine, Measles vaccine, Placebo)
Recruiting
- Vaccine Preventable Disease
- +3 more
- BCG vaccine
- +2 more
-
Bissau, Bissau Codex, Guinea-BissauBandim Health Project
May 23, 2021
Tuberculosis Trial in Worcester (MTBVAC, BCG)
Completed
- Tuberculosis
- MTBVAC
- BCG
-
Worcester, Western Cape, South AfricaSATVI: Worcester
Aug 26, 2022
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Filarial Infections on Tuberculosis Disease and Tuberculosis
Recruiting
- Tuberculosis
- TB treatment according to national guidelines
-
Buea, CameroonUniversity of Buea
Nov 22, 2021
BCG Vaccination Reaction Trial (bcg vaccine)
Not yet recruiting
- BCG Vaccination Reaction
- bcg vaccine
- (no location specified)
Mar 13, 2021
Allergy, Eczema, Respiratory Tract Infections Trial in Heidelberg, Melbourne (BCG)
Active, not recruiting
- Allergy
- +2 more
- BCG
-
Heidelberg, Victoria, Australia
- +1 more
Mar 15, 2021
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
COVID-19, Vaccine Reaction, Immunization; Infection Trial in Parkville (Tozinameran)
Active, not recruiting
- COVID-19
- +2 more
- Tozinameran
-
Parkville, Victoria, AustraliaMelbourne Children's campus
Feb 8, 2022
Tuberculosis Trial in South Africa (BCG vaccine SSI, Placebo)
Active, not recruiting
- Tuberculosis
- BCG vaccine SSI
- Placebo
-
Klipfontein, Cape Town, South Africa
- +4 more
Aug 10, 2021
Mycobacterium Tuberculosis Infection Trial in Worldwide (VPM1002, BCG SII)
Active, not recruiting
- Mycobacterium Tuberculosis Infection
- VPM1002
- BCG SII
-
Lambaréné, Gabon
- +11 more
Dec 19, 2022
BCG, COVID-19, SARS-CoV2 Trial in Monterrey (BCG vaccine, Placebo)
Active, not recruiting
- BCG
- +3 more
- BCG vaccine
- Placebo
-
Monterrey, Nuevo León, MexicoHospital Universitario "José E. González"
Nov 12, 2020
Prevention of TB Recurrence Trial in Bangladesh, India (VPM1002 (Recombinant BCG Vaccine), Placebo)
Recruiting
- Prevention of TB Recurrence
- VPM1002 (Recombinant BCG Vaccine)
- Placebo
-
Dhaka, Bangladesh
- +9 more
Sep 4, 2021
Tuberculosis Trial in Worcester (MTBVAC, BCG)
Completed
- Tuberculosis
- MTBVAC
- BCG
-
Worcester, South AfricaSATVI: Worcester
Sep 6, 2021
Covid19 Trial (BCG Vaccine, Placebo)
Withdrawn
- Covid19
- BCG Vaccine
- Placebo
- (no location specified)
Jun 23, 2021
COVID-19 Trial (Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine, Preservative-free saline)
Withdrawn
- COVID-19
- Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine
- Preservative-free saline
- (no location specified)
Mar 23, 2021
COVID-19, Virus Diseases, Corona Virus Infection Trial in Greece (BCG vaccine, Placebo)
Completed
- COVID-19
- +4 more
- BCG vaccine
- Placebo
-
Náfplio, Argos, Greece
- +14 more
May 9, 2021
Heterologous Immunity, Infant Morbidity, Infant Mortality Trial in Bissau (BCG-Japan, BCG-Russia)
Completed
- Heterologous Immunity
- +5 more
- BCG-Japan
- BCG-Russia
-
Bissau, Guinea-Bissau
- +1 more
Dec 13, 2020
Coronavirus Disease (COVID-19) Trial in Cairo (intradermal injection of BCG Vaccine, )
Unknown status
- Coronavirus Disease (COVID-19)
- intradermal injection of BCG Vaccine
- placebo
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Apr 17, 2020
Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)
Active, not recruiting
- Safety
- Immunogenicity
- ChAdOx185A
- +2 more
-
Entebbe, Uganda
- +1 more
May 13, 2021
Tuberculosis Trial in Dar es Salaam (DAR-901, Sterile saline )
Completed
- Tuberculosis
- DAR-901
- Sterile saline placebo
-
Dar es Salaam, TanzaniaMuhimbili University of Health and Allied Sciences
Apr 17, 2021
COVID-19 Trial in Medellín (vaccine BCG, Placebo)
Withdrawn
- COVID-19
- vaccine BCG
- Placebo
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Nov 24, 2020